QBW-276

N/A

Report date: 2023/04/24 20:00:24

NME

Base Information

Drug NameQBW-276

Drug Alias NameNME-QBW-276QBW-276

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCystic fibrosis transmembrane conductance regulator modulators

TargetsCystic fibrosis transmembrane conductance regulator

Therapy Area/IndicationsCystic Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesGermany

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNovartis Pharma Ag

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsCystic Fibrosis

ATC CodeN/A